We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ABBV34 market cap is 91.45B. The company's latest EPS is USD 2.7544 and P/E is 59.46.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 14.81B | 15.12B | 12.24B | 14.03B | 13.93B |
Operating Income | 4.78B | 5.5B | 2.77B | 4.51B | 2.28B |
Net Income | 3.95B | 2.47B | 239M | 2.02B | 1.78B |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 34.16B | 45.8B | 56.2B | 58.05B | 54.5B |
Operating Income | 12.98B | 11.36B | 17.92B | 18.12B | 12.76B |
Net Income | 7.88B | 4.62B | 11.54B | 11.84B | 4.86B |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 141.33B | 138.81B | 134.54B | 135.37B | 136.22B |
Total Liabilities | 125.3B | 121.52B | 121.24B | 122.47B | 124.09B |
Total Equity | 16.03B | 17.29B | 13.3B | 12.9B | 12.13B |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 89.12B | 150.57B | 146.53B | 138.81B | 134.71B |
Total Liabilities | 97.29B | 137.47B | 131.09B | 121.52B | 124.31B |
Total Equity | -8.17B | 13.1B | 15.44B | 17.29B | 10.4B |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 17.52B | 24.94B | 4.19B | 10.51B | 18.09B |
Investing | -175M | -623M | -499M | -840M | -1.21B |
Financing | -15.17B | -24.8B | -6.19B | -10.11B | -12.77B |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 13.32B | 17.59B | 22.78B | 24.94B | 22.84B |
Investing | 596M | -37.56B | -2.34B | -623M | -2.01B |
Financing | 18.71B | -11.5B | -19.04B | -24.8B | -17.22B |
Market Cap | 91.45B |
Price to Earnings Ratio | 59.46 |
Price to Sales Ratio | 5.31 |
Price to Cash Ratio | 22.57 |
Price to Book Ratio | 27.81 |
Dividend Yield | - |
Shares Outstanding | 1.77B |
Average Volume (1 week) | 4.62k |
Average Volume (1 Month) | 1.08k |
52 Week Change | 9.77% |
52 Week High | 57.77 |
52 Week Low | 39.68 |
Spread (Intraday) | 3.92 (7.17%) |
Company Name | Abbvie Inc |
Address |
1521 concord pike suite 201 wilmington, delaware 19803 |
Website | https://www.abbvie.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions